Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Liabilities (2022 - 2025)

Historic Total Liabilities for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $61.1 million.

  • Orchestra BioMed Holdings' Total Liabilities rose 10985.57% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.1 million, marking a year-over-year increase of 10985.57%. This contributed to the annual value of $43.2 million for FY2024, which is 5906.0% up from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Total Liabilities of $61.1 million as of Q3 2025, which was up 10985.57% from $42.5 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Total Liabilities registered a high of $61.1 million during Q3 2025, and its lowest value of $5.9 million during Q1 2022.
  • In the last 4 years, Orchestra BioMed Holdings' Total Liabilities had a median value of $36.4 million in 2023 and averaged $31.4 million.
  • Over the last 5 years, Orchestra BioMed Holdings' Total Liabilities had its largest YoY gain of 51843.33% in 2023, and its largest YoY loss of 3687.21% in 2023.
  • Over the past 4 years, Orchestra BioMed Holdings' Total Liabilities (Quarter) stood at $43.0 million in 2022, then crashed by 36.87% to $27.2 million in 2023, then surged by 59.06% to $43.2 million in 2024, then soared by 41.31% to $61.1 million in 2025.
  • Its Total Liabilities was $61.1 million in Q3 2025, compared to $42.5 million in Q2 2025 and $42.2 million in Q1 2025.